Chronic viral hepatitis is a chronic viral disease of the liver; the sources supplied use the term as a broad disease category rather than defining a single etiologic agent [1][2][3]. In the available literature, it is discussed within chronic liver disease pathways in which persistent inflammation can contribute to progressive hepatic injury [4]. The record provided does not identify the specific viral types encompassed by this label, so source-backed detail on etiologic subtyping is not yet available [1][2][3].
Disease Profile
Chronic viral hepatitis
慢性病毒性肝炎
Chronic viral hepatitis is a chronic liver disease category identified here by ICD-10 B18 and ICD-11 1E50, but the provided source snippets do not specify the causative viruses or provide a formal definitional description beyond the umbrella term itself [1][2][3]. The available evidence links chronic viral hepatitis to chronic liver injury, including fibrosis, cirrhosis, and eventual liver failure, and notes its role in the burden of liver fibrosis worldwide [4][5]. Because the evidence set is limited, disease-specific natural history, transmission particulars, and prevention measures are only partially supported here [4][5].
The supplied sources characterize chronic liver disease progression as involving fibrosis, cirrhosis, and eventually liver failure when inflammation is not restrained [4]. Liver fibrosis is described as a major cause of morbidity and mortality worldwide due in part to chronic viral hepatitis, with hepatic stellate cell activation identified as a critical event in fibrogenesis [5]. These snippets support a chronic, progressive hepatobiliary disease course, but they do not describe symptom patterns, timing, decompensation features, or complication frequencies in detail [4][5]. Source-backed detail on specific clinical manifestations is therefore not yet available.
The evidence provided indicates that liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis, placing the condition within a global chronic liver disease burden [5]. One review also groups chronic viral hepatitis among common chronic liver diseases discussed in relation to the oral-gut-liver axis, alongside cirrhosis and hepatocellular cancer [4]. The snippets do not provide geographic distribution by region, age, sex, outbreak context, or surveillance incidence estimates, so those epidemiologic details are not yet available from the source set [4][5].
The source material provided does not describe the transmission route, exposure mechanism, or reservoir for chronic viral hepatitis [1][2][3]. It only establishes that the disease belongs to the viral hepatitis category and is discussed in the context of chronic liver disease progression [4][5]. Source-backed transmission detail is therefore not yet available.
The source set does not specify particular high-risk age groups, occupational groups, household contacts, or behavioral exposure categories for chronic viral hepatitis [1][2][3]. It does indicate that chronic liver disease progression occurs in susceptible hosts in the setting of prolonged immune activation and unresolved inflammation, but does not define who those hosts are [4]. Source-backed risk-group detail is therefore not yet available.
The supplied snippets do not provide specific prevention measures, vaccination information, screening strategies, or exposure-control recommendations for chronic viral hepatitis [1][2][3]. They do, however, indicate that persistent inflammation and fibrosis are central to chronic liver disease progression, which supports the public-health relevance of early recognition and control of ongoing hepatic injury [4][5]. Beyond that general implication, source-backed preventive guidance is not yet available.
For surveillance purposes, chronic viral hepatitis should be interpreted as a chronic liver disease category rather than a fully specified etiologic diagnosis in the provided record [1][2][3]. The evidence set supports monitoring for downstream outcomes such as fibrosis, cirrhosis, and liver failure, which are described as key consequences of chronic liver injury and chronic viral hepatitis–related fibrosis [4][5]. Because the snippets do not identify virus-specific markers or case definitions, monitoring detail should remain conservative and limited to the available chronic liver disease framework [4][5].
- 1 Chronic viral hepatitis. The Indian Journal of Pediatrics. 1995. doi: 10.1007/bf02825113. DOI: https://doi.org/10.1007/bf02825113
- 2 Chronic Viral Hepatitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2015. doi: 10.5005/jp/books/12548_25. DOI: https://doi.org/10.5005/jp/books/12548_25
- 3 Chronic Viral Hepatitis. Pediatric Hepatology and Liver Transplantation. 2019. doi: 10.1007/978-3-319-96400-3_9. DOI: https://doi.org/10.1007/978-3-319-96400-3_9
- 4 Albuquerque-Souza E et al. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. Periodontol 2000. 2022 Jun. PMID: 35244954. doi: 10.1111/prd.12427. PubMed: https://pubmed.ncbi.nlm.nih.gov/35244954/
- 5 Hernandez-Gea V et al. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011. PMID: 21073339. doi: 10.1146/annurev-pathol-011110-130246. PubMed: https://pubmed.ncbi.nlm.nih.gov/21073339/
- 6 Abenavoli L et al. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010 Oct. PMID: 20564545. doi: 10.1002/ptr.3207. PubMed: https://pubmed.ncbi.nlm.nih.gov/20564545/
- B18
- 1E50
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.